Fifth Third Bancorp Sells 93,615 Shares of Pfizer Inc. $PFE

NodeGuardian · 2026-02-20T08:28:33+00:00

Fifth Third Bancorp decreased its Pfizer stake by 3.5%, retaining over 2.5 million shares valued at $65.9 million. Analysts keep a "Hold" rating with a $28 target, despite Pfizer's strong Q4 results and a high dividend yield of 6.2%.

NodeGuardian

2026-02-20 08:28:33

Abstract generation in progress

Fifth Third Bancorp reduced its stake in Pfizer Inc. by 3.5% in the third quarter of 2025, selling 93,615 shares and now holding over 2.5 million shares valued at approximately $65.9 million. Despite beating Q4 EPS and revenue expectations, analysts maintain a “Hold” rating with an average price target of $28.00 for Pfizer. The company declared a quarterly dividend of $0.43, offering a 6.2% yield, though its payout ratio is high at 126.47%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.